Mutya Harsch
2022
In 2022, Mutya Harsch earned a total compensation of $654.4K as Chief Legal Officer, General Counsel and Secretary at VYNE Therapeutics, a 50% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $143,538 |
|---|---|
| Option Awards | $30,750 |
| Salary | $422,172 |
| Stock Awards | $45,750 |
| Other | $12,200 |
| Total | $654,410 |
Harsch received $422.2K in salary, accounting for 65% of the total pay in 2022.
Harsch also received $143.5K in non-equity incentive plan, $30.8K in option awards, $45.8K in stock awards and $12.2K in other compensation.
Rankings
In 2022, Mutya Harsch's compensation ranked 3,903rd out of 5,756 executives tracked by ExecPay. In other words, Harsch earned more than 32.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,903 out of 5,756 | 32nd |
Division Manufacturing | 2,206 out of 3,133 | 30th |
Major group Chemicals And Allied Products | 1,067 out of 1,419 | 25th |
Industry group Drugs | 1,001 out of 1,320 | 24th |
Industry Pharmaceutical Preparations | 733 out of 966 | 24th |
Source: SEC filing on November 13, 2023.
Harsch's colleagues
We found two more compensation records of executives who worked with Mutya Harsch at VYNE Therapeutics in 2022.
News
VYNE Therapeutics CEO David Domzalski's 2023 pay jumps 110% to $2.7M
November 12, 2024
VYNE Therapeutics CEO David Domzalski's 2022 pay falls 73% to $1.3M
November 13, 2023
VYNE Therapeutics CEO David Domzalski's 2021 pay jumps 69% to $4.9M
June 17, 2022
VYNE Therapeutics CEO David Domzalski receives $2.9M in 2020
June 7, 2021